Gatifloxacin hydrate

加替沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameGatifloxacin hydrate
Drug Alias Name盖替沙星gatifloxacinoGatifloxacinum加替沙星水合物gatifloxacine +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsKeratitisOtitis MediaOtitis Externa +[10] 
Global Approved IndicationsEye InfectionsConjunctivitis, Bacterial
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/03/28
Country/TerritoryBeninUnited StatesSenegal +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesSino--American Shanghai Squibb Pharmaceutical LtdBoji Medical Technology Co LtdSenju Pharmaceutical Co Ltd
Inactive CompaniesInstitut De Recherche Pour Le DeveloppementAllergan Plc
Active IndicationsOtitis MediaOtitis ExternaCholesteatoma, Middle Ear +[5] 
Inactive IndicationsKeratitisOtitis Media, SuppurativeCorneal Ulcer +[5] 

Other Information

ATC CodeJ01MA16S01AE06
Related LinksWikipediaDrugBankKEGG